An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata
Allergy2021Vol. 76(10), pp. 3053–3065
Citations Over TimeTop 10% of 2021 papers
Jacob W. Glickman, Celina Dubin, Dante Dahabreh, Joseph Han, Ester Del Duca, Yeriel Estrada, Ning Zhang, Grace W. Kimmel, Giselle Singer, James G. Krueger, Ana B. Pavel, Emma Guttman‐Yassky
Abstract
This study contributes a unique understanding of the phenotype of moderate-to-severe AA with an integrated scalp and serum biomarker model suggesting the systemic nature of the disease, advocating for the need for immune-based systemic treatment.
Related Papers
- → Serum Zinc Concentration in Patients with Alopecia Areata(2023)13 cited
- → Prevalence of Comorbid Conditions and Sun-Induced Skin Cancers in Patients with Alopecia Areata(2015)27 cited
- → Congenital Alopecia areata(1997)27 cited
- → Alopecia Areata(2021)1 cited
- → Evidence Based Treatment of Alopecia Areata(2017)